OBJECTIVE: To detail the distribution of causes of death from localized prostate cancer (PCa). PATIENTS AND METHODS: The database PCBase Sweden links the Swedish National Prostate Cancer Register with other nationwide population-based healthcare registers. We selected all 57 187 men diagnosed with localized PCa between 1997 and 2009 and their 114 374 PCa-free control subjects, matched according to age and county of residence. Mortality was calculated using competing risk regression analyses, taking into account PCa risk category, age and Charlson comorbidity index (CCI). RESULTS: In men with low-risk PCa, all-cause mortality was lower compared with that in corresponding PCa-free men: 10-year all-cause mortality was 18% for men diagnosed at ...
In the early 20th century, cancer of the prostate was considered a rare and deadly disease with litt...
BACKGROUND: Although the true benefits and disadvantages of prostate cancer screening are still not ...
BACKGROUND: Prostate cancer is one of the leading causes of death from malignant disease among men i...
Background: There are limited prognostic data for locally advanced prostate cancer PCa to guide in t...
Objective: To assess the strength of the evidence indicative of prostate cancer (PCa) progression as...
Background. A recent rise in the incidence of prostate cancer and a more favorable outcome have incr...
OBJECTIVE: To investigate causes of death in a UK cohort of patients with prostate cancer. PATIENTS ...
Background: Attempts to reduce prostate cancer (PC) mortality require an understanding of temporal c...
Background and Objective Changes in diagnostic work-up, histopathological assessment, and treatment ...
Objective To evaluate whether the effects of radical treatment in men with locally advanced prostate...
Background: Current guidelines recommend androgen deprivation therapy only for men with very high-ri...
OBJECTIVE: The purpose of this study was to examine the proportion of men who died from prostate can...
PURPOSE To assess the risk of prostate cancer (PCa) specific mortality (PCSM) compared to cardiovas...
PurposeThe risk of cardiovascular disease (CVD) mortality in patients with localized prostate cancer...
PurposeThe risk of cardiovascular disease (CVD) mortality in patients with localized prostate cancer...
In the early 20th century, cancer of the prostate was considered a rare and deadly disease with litt...
BACKGROUND: Although the true benefits and disadvantages of prostate cancer screening are still not ...
BACKGROUND: Prostate cancer is one of the leading causes of death from malignant disease among men i...
Background: There are limited prognostic data for locally advanced prostate cancer PCa to guide in t...
Objective: To assess the strength of the evidence indicative of prostate cancer (PCa) progression as...
Background. A recent rise in the incidence of prostate cancer and a more favorable outcome have incr...
OBJECTIVE: To investigate causes of death in a UK cohort of patients with prostate cancer. PATIENTS ...
Background: Attempts to reduce prostate cancer (PC) mortality require an understanding of temporal c...
Background and Objective Changes in diagnostic work-up, histopathological assessment, and treatment ...
Objective To evaluate whether the effects of radical treatment in men with locally advanced prostate...
Background: Current guidelines recommend androgen deprivation therapy only for men with very high-ri...
OBJECTIVE: The purpose of this study was to examine the proportion of men who died from prostate can...
PURPOSE To assess the risk of prostate cancer (PCa) specific mortality (PCSM) compared to cardiovas...
PurposeThe risk of cardiovascular disease (CVD) mortality in patients with localized prostate cancer...
PurposeThe risk of cardiovascular disease (CVD) mortality in patients with localized prostate cancer...
In the early 20th century, cancer of the prostate was considered a rare and deadly disease with litt...
BACKGROUND: Although the true benefits and disadvantages of prostate cancer screening are still not ...
BACKGROUND: Prostate cancer is one of the leading causes of death from malignant disease among men i...